REQUEST A DEMO
Total
USD $0.00
Search more companies

Alloes Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Alloes Pharmaceuticals Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Alloes Pharmaceuticals Private Limited is an unlisted company, incorporated on 21/11/2003. It has its registered office in the State of Gujarat, India. Company's corporate identification number (CIN) is U24232GJ2003PTC043220 and registration number is 043220. The company is a trade company, it is engaged in wholesale trading.

Legal Address
210-A,Infinity Tower, Sur No. 884,Tp-25, Sp-5, Near Ramdev Hotel, Corporate Road, Prahladnagar
Ahmedabad; Gujarat; Postal Code: 380015

Contact Details: Purchase the Alloes Pharmaceuticals Private Limited report to view the information.

Website: http://alloespharma.com

Basic Information
Total Employees:
Purchase the Alloes Pharmaceuticals Private Limited report to view the information.
Outstanding Shares:
Purchase the Alloes Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Alloes Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
November 21, 2003
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Alloes Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
11.91%
Total operating revenue
12.07%
Operating profit (EBIT)
-43.73%
EBITDA
-42.92%
Net Profit (Loss) for the Period
-54.14%
Total assets
59.33%
Total equity
7.14%
Operating Profit Margin (ROS)
-1.61%
Net Profit Margin
-1.81%
Return on Equity (ROE)
-18.63%
Debt to Equity Ratio
323.14%
Quick Ratio
-0.39%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?